JP2023528755A5 - - Google Patents
Info
- Publication number
- JP2023528755A5 JP2023528755A5 JP2022569071A JP2022569071A JP2023528755A5 JP 2023528755 A5 JP2023528755 A5 JP 2023528755A5 JP 2022569071 A JP2022569071 A JP 2022569071A JP 2022569071 A JP2022569071 A JP 2022569071A JP 2023528755 A5 JP2023528755 A5 JP 2023528755A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063038024P | 2020-06-11 | 2020-06-11 | |
| US63/038,024 | 2020-06-11 | ||
| US202063045728P | 2020-06-29 | 2020-06-29 | |
| US63/045,728 | 2020-06-29 | ||
| US202163178203P | 2021-04-22 | 2021-04-22 | |
| US63/178,203 | 2021-04-22 | ||
| PCT/US2021/036873 WO2021252799A2 (en) | 2020-06-11 | 2021-06-10 | Compounds and methods for reducing msh3 expression |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023528755A JP2023528755A (ja) | 2023-07-06 |
| JPWO2021252799A5 JPWO2021252799A5 (https=) | 2024-06-17 |
| JP2023528755A5 true JP2023528755A5 (https=) | 2024-06-17 |
Family
ID=78846536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022569071A Pending JP2023528755A (ja) | 2020-06-11 | 2021-06-10 | Ｍｓｈ３の発現を低減するための化合物及び方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20230235331A1 (https=) |
| EP (1) | EP4164656A4 (https=) |
| JP (1) | JP2023528755A (https=) |
| WO (1) | WO2021252799A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021226549A1 (en) * | 2020-05-08 | 2021-11-11 | Triplet Therapeutics, Inc. | Methods for the treatment of nucleotide repeat expansion disorders associated with msh3 activity |
| CN119173632A (zh) * | 2022-05-10 | 2024-12-20 | 豪夫迈·罗氏有限公司 | 靶向cfp-elk1基因间区域的反义寡核苷酸 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003207708A1 (en) * | 2002-02-20 | 2003-09-09 | Sirna Therapeutics, Inc. | Rna interference mediated inhibition of map kinase genes |
| EP2462937A1 (en) * | 2005-05-24 | 2012-06-13 | Isis Pharmaceuticals, Inc. | Modulation of LMW-PTPase Expression |
| US10174328B2 (en) * | 2013-10-04 | 2019-01-08 | Translate Bio Ma, Inc. | Compositions and methods for treating amyotrophic lateral sclerosis |
| WO2015171918A2 (en) * | 2014-05-07 | 2015-11-12 | Louisiana State University And Agricultural And Mechanical College | Compositions and uses for treatment thereof |
| WO2016106387A2 (en) * | 2014-12-22 | 2016-06-30 | University Of Iowa Research Foundation | Nucleic acid aptamers to treat histone-induced disease states |
| JP2019507579A (ja) * | 2015-10-28 | 2019-03-22 | クリスパー セラピューティクス アーゲー | デュシェンヌ型筋ジストロフィーの処置のための材料および方法 |
| JP7714162B6 (ja) * | 2018-12-03 | 2025-09-08 | タケダ ファーマシューティカルズ ユーエスエー インコーポレイテッド | Ｍｓｈ３活性に関連するトリヌクレオチドリピート伸長障害の処置のための方法 |
| US20210355491A1 (en) * | 2020-04-20 | 2021-11-18 | University Of Massachusetts | Oligonucleotides for msh3 modulation |
| WO2021226549A1 (en) * | 2020-05-08 | 2021-11-11 | Triplet Therapeutics, Inc. | Methods for the treatment of nucleotide repeat expansion disorders associated with msh3 activity |
-
2021
- 2021-06-10 EP EP21820917.9A patent/EP4164656A4/en active Pending
- 2021-06-10 JP JP2022569071A patent/JP2023528755A/ja active Pending
- 2021-06-10 US US18/001,241 patent/US20230235331A1/en active Pending
- 2021-06-10 WO PCT/US2021/036873 patent/WO2021252799A2/en not_active Ceased